ALKERMES | Capitalisation Boursière



Market Capitalization Changement Date
AbbVie USD 350.71B 19.93B 2025-05
Acadia Pharmaceuticals USD 2.85B 80M 2025-05
ALKERMES USD 5.14B 301M 2025-05
Amgen USD 150.93B 16.57B 2025-05
Biogen USD 17.99B 2.04B 2025-05
BioMarin Pharmaceutical USD 11.82B 1.73B 2025-05
Bristol-Myers Squibb USD 101.53B 22.57B 2025-05
Eli Lilly USD 782B 40.35B 2025-05
Gilead Sciences USD 128.54B 11.15B 2025-05
Ionis Pharmaceuticals USD 4.88B 80M 2025-05
J&J USD 373.47B 26.18B 2025-05
Merck USD 208.29B 17.59B 2025-05
Neurocrine Biosciences USD 10.91B 2.91B 2025-05
Otsuka Holdings JPY 4.13T 145.84B 2025-05
Pfizer USD 135.11B 8.61B 2025-05
Regeneron Pharmaceuticals USD 66.28B 3.05B 2025-05
Vertex Pharmaceuticals USD 130.09B 26.64B 2025-05



ALKERMES Capitalisation Boursière - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.